Trial Profile
Trial in diabetic ulcer Using basic Fibroblast Growth Factor(KCB-1).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2009
Price :
$35
*
At a glance
- Drugs Trafermin (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Kaken Pharmaceutical
- 15 Sep 2009 New trial record